Abstract
Antibody-dependent cell-mediated cytotoxicity (ADCC) was measured in nasopharyngeal secretions collected from 42 infants and young children at various intervals after primary or secondary infection with respiratory syncytial virus. ADCC was determined by specific immune release of 51Cr from respiratory syncytial virus-infected HEp-2 cell culture monolayers, with lymphocytes from adult volunteers as effector cells. Specific ADCC responses in nasopharyngeal secretions after primary infection were observed as early as 3 days after the onset of clinical symptoms, and peak activity was observed 14 to 29 days after the onset of illness. ADCC responses after reinfection were significantly greater in both the acute and convalescent phases (P less than 0.05) than were ADCC responses after primary infection. ADCC in secretions was mediated primarily by the immunoglobulin G isotype of respiratory syncytial virus antibody.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beem M. Repeated infections with respiratory syncytial virus. J Immunol. 1967 Jun;98(6):1115–1122. [PubMed] [Google Scholar]
- Cranage M. P., Gardner P. S., McIntosh K. In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions. Clin Exp Immunol. 1981 Jan;43(1):28–35. [PMC free article] [PubMed] [Google Scholar]
- Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979 Jan;122(1):175–181. [PubMed] [Google Scholar]
- Hall C. B., Douglas R. G., Jr, Simons R. L., Geiman J. M. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr. 1978 Jul;93(1):28–32. doi: 10.1016/s0022-3476(78)80594-0. [DOI] [PubMed] [Google Scholar]
- Henderson F. W., Collier A. M., Clyde W. A., Jr, Denny F. W. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979 Mar 8;300(10):530–534. doi: 10.1056/NEJM197903083001004. [DOI] [PubMed] [Google Scholar]
- Kaul T. N., Welliver R. C., Ogra P. L. Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus. J Clin Microbiol. 1981 May;13(5):957–962. doi: 10.1128/jcm.13.5.957-962.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaul T. N., Welliver R. C., Wong D. T., Udwadia R. A., Riddlesberger K., Ogra P. L. Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child. 1981 Nov;135(11):1013–1016. doi: 10.1001/archpedi.1981.02130350017007. [DOI] [PubMed] [Google Scholar]
- Kim H. W., Arrobio J. O., Brandt C. D., Jeffries B. C., Pyles G., Reid J. L., Chanock R. M., Parrott R. H. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol. 1973 Sep;98(3):216–225. doi: 10.1093/oxfordjournals.aje.a121550. [DOI] [PubMed] [Google Scholar]
- Levine S., Hamilton R. Kinetics of the respiratory syncytial virus growth cycle in HeLa cells. Arch Gesamte Virusforsch. 1969;28(2):122–132. doi: 10.1007/BF01249378. [DOI] [PubMed] [Google Scholar]
- McIntosh K., Masters H. B., Orr I., Chao R. K., Barkin R. M. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis. 1978 Jul;138(1):24–32. doi: 10.1093/infdis/138.1.24. [DOI] [PubMed] [Google Scholar]
- McIntosh K., McQuillin J., Gardner P. S. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun. 1979 Feb;23(2):276–281. doi: 10.1128/iai.23.2.276-281.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meguro H., Kervina M., Wright P. F. Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties. J Immunol. 1979 Jun;122(6):2521–2526. [PubMed] [Google Scholar]
- Mills J., 5th, Van Kirk J. E., Wright P. F., Chanock R. M. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol. 1971 Jul;107(1):123–130. [PubMed] [Google Scholar]
- Parrott R. H., Kim H. W., Arrobio J. O., Hodes D. S., Murphy B. R., Brandt C. D., Camargo E., Chanock R. M. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol. 1973 Oct;98(4):289–300. doi: 10.1093/oxfordjournals.aje.a121558. [DOI] [PubMed] [Google Scholar]
- Scott R., de Landazuri M. O., Gardner P. S., Owen J. J. Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus. Clin Exp Immunol. 1977 Apr;28(1):19–26. [PMC free article] [PubMed] [Google Scholar]
- Shen L., Fanger M. W. Secretory IgA antibodies synergize with IgG in promoting ADCC by human polymorphonuclear cells, monocytes, and lymphocytes. Cell Immunol. 1981 Mar 15;59(1):75–81. doi: 10.1016/0008-8749(81)90435-4. [DOI] [PubMed] [Google Scholar]
- Welliver R. C., Kaul A., Ogra P. L. Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr. 1979 Mar;94(3):370–375. doi: 10.1016/s0022-3476(79)80573-9. [DOI] [PubMed] [Google Scholar]
- Welliver R. C., Kaul T. N., Putnam T. I., Sun M., Riddlesberger K., Ogra P. L. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr. 1980 May;96(5):808–813. doi: 10.1016/s0022-3476(80)80547-6. [DOI] [PubMed] [Google Scholar]